Published Date : Feb 21, 2018
ALBANY, New York, February 21, 2018 – A recent business intelligence publication on the global cloud computing market in the pharmaceutical industry is now available at the prestigious repository of MarketResearchReports.biz. The report, titled “Global Cloud Computing in Pharmaceutical Market Size, Status and Forecast 2025,” is a summation of how the emerging technology of cloud computing can revolutionize the forever growing field of pharmaceuticals. The analysts of the report have projected the demand to expand at a notable CAGR during the forecast period of 2017 to 2025.
This report on the global cloud computing in pharmaceutical market is a quantitative and qualitative study of how the demand is evolving in this relatively new segment of the healthcare industry and what its growth prospects are. Embarking with an executive summary that broadly elaborated the finer aspects of the market, the report contains in-depth reports of all factors such as opportunities, trends, driver, and challenges that will determine the demand in the near future. Understanding the need to highlight most profitable avenues of the market, the report segments the cloud computing in pharmaceutical market product and application. Geographically, the report evaluates the potential of demand that can be expected out of every important region and country. To complete a thorough study, the report included a featured section on the competitive landscape of the global cloud computing in pharmaceutical market, wherein several leading players have been profiled for their market presence on the basis of each segments, revenue and operating profits, SWOT reports, and recent strategic decisions.
For Sample Copy, click here: https://www.marketresearchreports.biz/sample/sample/1491110
It has been observed that cloud computing has strong potential in how drugs are discovered and developed in the pharmaceutical sector as well as address some of its key challenges such as providing information to the researchers on a real-time basis. These possibilities of faster innovation is the primary driver of the global cloud computing in pharmaceutical market. It has also been observed that there are reoccurring issues pertaining to snowflake solutions, data residency, and internal against public cloud that can be adopted by the industry. On the other hand, cost factors are expected to hinder the growth of the global market for cloud computing in the pharmaceutical industry.
Based on product type, the report segments the cloud computing in pharmaceutical market into software as a service (SaaS), infrastructure as a service (IaaS), and platform as a service (PaaS). Application-wise, the market has been bifurcated into production management system (PMS), EMR, online sales, and others. Geographically, the report takes stock of the potential of demand that can be expected from the countries of the United States, China, Japan, and India as well as from the regions of Southeast Asia and Europe. Currently, the U.S. and Europe are the two most lucrative regions on the back of the presence of a number of leading companies of this market and are expected to hold their strong position throughout the forecast period. However, the emerging economies of Japan, China, and India are expected to showcase tremendous growth in the near future.
The report profiles a number of key companies of the global cloud computing in pharmacentucal market, including Amazon, IBM, Cisco Systems, HP, Flexiant, Oracle, Dell, Microsoft, SAP AG, Google, Akamai, Carestream Health, Etelos, Yahoo, Gogrid, ClearData Networks, Enki Consulting, VMware, and Athenahealth CareCloud. For each of these companies, the report includes information their revenue in million USD, main business and overview, products, services, and solutions, and recent developments. The report also contains information how these companies have evolved during the period of 2013 to 2018.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org